GET THE APP

The Secretome of Mycoplasma capricolum subsp. capricolum in Neutr
Journal of Proteomics & Bioinformatics

Journal of Proteomics & Bioinformatics
Open Access

ISSN: 0974-276X

+44 1223 790975

Research Article - (2015) Volume 8, Issue 7

The Secretome of Mycoplasma capricolum subsp. capricolum in Neutral and Acidic Media

Amanda Voros, Johanna DeLongchamp and Mazen Saleh*
Department of Biology, Laurentian University, 935 Ramsey Lake Road, Sudbury, Ontario, P3E 2C6, Canada
*Corresponding Author: Dr. Mazen Saleh, Department of Biology, Laurentian University, 935 Ramsey Lake Road, Sudbury, Ontario, P3E 2C6, Canada, Tel: 705-675-1151, Fax: (705) 675-4859

Abstract

Mycoplasmas have proven to be successful pathogens despite their minimal genomes in some species. Their simplistic nature makes them an important tool for understanding the genes involved in basic metabolic processes and pathogenesis. Of particular interest are the genes involved in mycoplasma evasion of host immune responses and survival within phagocytic cells. The proteins secreted by mycoplasmas in the acidic and hydrolytic environment of a macrophage may help to uncover important virulence factors of this group of prokaryotes.

This study examined the effect of pH on the secretome of Mycoplasma capricolum. The bacterium was cultured in protein-free media and the culture supernatant was investigated for proteins produced during growth. Twodimensional gel electrophoresis followed by MALDI-TOF mass spectrometry of tryptic digests was used to identify the proteins in this fraction.

Under acidic conditions, a total of a 111 protein spots from the secretome of M. capricolum were visualized by silver staining. A lower number of spots were detected in the neutral culture supernatant (82 spots). Superimposition of the two 2D maps revealed 26 proteins unique to the secretome at acidic pH but identification of all spots was not possible. The identification of neutral proteins revealed the presence of 7 putative lipoproteins, zinc metalloprotease, three peptidases, inorganic pyrophosphatase, nicotinamidase/pyrazinamidase, and ribosomal protein S4, and a number of hypothetical proteins. Proteins identified in the acidic culture supernatant included hemolysin A, peptide methionine sulfoxide reductases, two peptidases, nucleoside kinase, one lipoprotein, and others. An API ZYM enzyme assay demonstrated that the spectrum of enzymes secreted at an acidic pH was similar to that at neutral pH, the activities of the acid phosphatase, the phosphohydrolase, the C8 esterase lipase and the alkaline phosphatase were enhanced. The three key secreted proteins prominent at acidic pH were the acid phosphatase, the hemolysin, and the gelatinase.

 

Keywords: Secretome, Mycoplasma, Capricolum, Proteomic, Acidic pH

Introduction

Members of the mycoplasmas are known to have some the smallest free-living prokaryotes. They are characterized by their small genomes (0.58 – 2.20 Mb) and lack of a cell wall [1]. The availability of complete genome sequences of several mycoplasmas provides a great opportunity to understand the minimal genome biology of these small bacteria [2]. Considerable advances have been made towards understanding the pathogenesis of mycoplasmas; of particular interest is the interaction of these pathogens with the immune system, macrophage activation, cytokine induction, superantigens, autoimmune manifestations, and the evasion of host immune responses. However, despite the wealth of new genetic information emerging from bacterial genome sequencing, many newly discovered genes remain functionally unclassified [3]. It is suggested that these mollicutes are phylogenetically related to Gram-positive bacteria whereby their genomes were reduced through multiple events of mutations. This implies that these simple bacteria are not found at the root of the phylogenetic tree but are more likely late evolutionary products [4]. Owing to their reduced genomes mycoplasmas have limited biosynthetic capabilities and therefore tend to take on a parasitic lifestyle in which they obtain nutrients and other metabolic building blocks such as amino acids, nucleotides, fatty acids, and sterols from their hosts [1]. Generally Mycoplasmas enter their host and multiply over long periods of time, slowly wearing down the host [1]. This is one reason perhaps why mycoplasmas have been linked to AIDS pathogenesis and to malignant transformation, chromosomal aberrations, the Gulf War Syndrome, and other unexplained and complex illnesses, including chronic fatigue syndrome, Crohn’s disease, and various arthritis’ [5]. These microorganisms have developed a variety of mechanisms in order to deal with host immune responses including; mimicry of host antigens, survival within phagocytic and non-phagocytic host cells and the generation of phenotypic plasticity [1]. One of the most important questions about the pathogenesis of mycoplasmas is how they cause damage to the host cells and to what extent is the damage clinically apparent in the host.

M. capricolum is the causative agent of caprine arthritis, mastitis, and respiratory disease [6]. The sophisticated antigenic variation of M. capricolum makes it difficult for the host immune system to produce effective antibodies to suppress the infection [6]. The accumulation of hydrolytic enzymes produced by this species also contributes to tissue damage during infection [6]. A better understanding of the pathogenesis of these bacterial infections may be the result of exposing the nature of virulence factors elaborated by these pathogens during growth. The secretome is of particular interest as it shows the potential for elaborating such virulence factors.

We have undertaken this study to characterize the secretome of M. capricolum using two-dimensional electrophoresis and mass spectrometry of tryptic digests. The results were compared to bioinformatics analysis of the secretome and supported with enzymatic characterization. This study provides new information and adds to the somewhat limited data on the biology of M. capricolum. Response of this pathogen to acidic pH provides a hint as to the mechanism of adaptation during infection and following phagocytic uptake in the host.

Materials and Methods

Bioinformatic analysis

The sequenced genome of M. capricolum (Accession # NC_007633) was retrieved from the World Wide Web NCBI site (www.ncbi.nlm. nih.gov/). The genome was first analyzed using the in-house program ExProt [7]. The program was used to identify the secreted / exported proteins of gram positive bacteria. The proteins that were predicted as being secreted or exported were further analyzed using the program SignalP 3.0 server (www.cbs.dtu.dk/services/SignalP/) [8]. The amino acid sequences of the Signal peptidase I proteins were processed through the SignalP 3.0 server, specified to analyze gram positive bacteria.

Growth

Complete growth media (Modified Eaton’s Medium, MEM) was composed of 8 g Mycoplasma Broth Base (Viragen, Ontario), 3.2 g of dextrose phenol red combination, and 100 ml of donor horse serum (The Cell Culture Company, PAA, Ontario), 100 μg/ml ampicillin (Sigma-Aldrich, St. Louis, MO) and 400 ml of distilled water, for a total final volume of 500 ml. The growth medium was modified in order to exclusively study the secretome of M. capricolum. The protein content was removed from the growth media by filtration through an Amicon filter (Millipore Stirred Cell 8400) with a 10,000 kDa cut off limit [9]. The culture medium was inoculated with Mycoplasma capricolum subsp. capricolum (California Kid type strain; kindly provided by Dr. Pascal Sirand-Pugnet, INRA, France) incubated at 37°C for 48 hours under 5% CO2. This culture was then spun down at 13,000 rpm for 30 minutes at 4°C (Beckman, GS-15R Centrifuge). The cell pellet was then resuspended and washed in phosphate buffered saline (PBS) and centrifuged at 13,000 rpm for 30 minutes at 4°C. This pellet was split and resuspended in either 150 ml of Amicon Modified culture medium (AM) buffered with 2-(N-morpholino)ethanesulfonic acid (MES) at pH 5.5 (acidic) or 150 ml of AM buffered with MES at pH 7.5 (neutral). Culture supernatants were collected by centrifugation at 13,000 rpm for 30 minutes at 4°C followed by filtration through a 0.22 μm filter.

API ZYM enzyme assay

API ZYM (bioMerieux, Durham, NC, USA), a system designed for the detection of enzyme activities with certain chromogenic substrates, was used to determine the presence or absence of certain enzymes in the culture supernatants. Approximately 10 μg (65 μl) of proteins form the neutral and acidic protein sample was dispensed into each of the 20 cupules of the individual strips. The strips were then placed into their respective incubation boxes with 5 ml of distilled water. After inoculation, the plastic lid was placed on the incubation box and the box was incubated for 4 hours at 37ºC. After the incubation period 20 μl of Fast Garnet GBC solution (5mls of 500 mM acetate buffer pH 6.2, and 2.5 mg/ml of Fast Garnet GBC salt) was added to each cupule on each strip and left exposed to daylight at room temperature for approximately 30 minutes until sufficient colour development had occurred.

Two-dimension SDS-PAGE

The volume of CFP used for isoelectric focussing was measured according to the protein concentration determined by the BCA protein assay. The immobilized pH gradient (IPG) strips (linear pH 3-10, 17- cm length, Bio-Rad) can accommodate up to 3 mg of protein while still maintaining proper protein resolution. Therefore volumes of CFP containing 3 mg of the Acidic CFP and 3mg of the neutral CFP were dried in the SpeedVac (DNA 120, Savant, Thermo Electron Corporation) for approximately 45 minutes at low heat. The dried CFPs were resuspended for 30 minutes in 350 μl of IPG rehydration buffer at room temperature (7M urea, 50mM dithiothreitol (DTT), 4% Chaps, 0.2% ampholytes, 0.001% bromophenol blue (BPB). The IPG strips were then rehydrated and isoelectric focussing (8-10,000V-hr at 20°C) was performed overnight (Protean IEF® Cell, Bio-Rad). IEF focusing conditions were the same for both the acidic and neutral CFPs. Once the first dimension was completed, the electrophoresed IPG strips were incubated for 20 minutes in equilibration buffer (6M urea, 0.375 M Tris HCl pH8.8, 2% sodium dodecyl sulphate (SDS), 20% glycerol) containing 2% DTT followed by and additional 20 minutes in equilibration buffer containing 2.5% iodoacetamide. Samples were subsequently subjected to the second dimension on a 10% separating gel (4% stacking) at a constant voltage of 200 V, and at 16 mA/gel for 30 minutes and 25 mA/gel for 5 hours using a vertical gel electrophoresis system by Whatman, Inc. Model V16-2 (Florham, NJ).

Silver staining

Proteins spots on the 17 cm 2D gels were visualized by silver staining methods (compatible with Mass Spectrometry analysis) based on the work of Blum et al. [10]. The gels underwent fixing in 40% methanol and 10% acetic acid. Two washes of 30% ethanol followed for 20 minutes each. A single wash of distilled H2O followed for 20 minutes. The sensitizer containing 0.02% DTT was then applied to the gels for 10 minutes followed by three washes of distilled H2O for 20 seconds each. The gels were placed in 0.2% silver nitrate for 20 minutes. Three washes of distilled H2O followed for 20 seconds each. The gels were developed with 2% sodium carbonate and 0.04% Formaldehyde until the spots became visible. Three washes of distilled H2O followed for 20 seconds each. The gels were placed in stop reagent containing 0.5% glycine overnight.

Mass spectrometry and protein identification

Protein spots of interest were manually excised from the 2D-gels and placed in siliconized sterile 1.5 ml microfuge tubes. In gel digestion and peptide extraction was based on a protocol provided by the manufacturer of the silver staining kit (Promega Inc.) with a modification of the protocol of Shevchenko et al. [11]. The protein spots were first destained by mixing in 50 μl of 50 mM ammonium bicarbonate, leaving them to sit for 5 minutes, and the wash solution was discarded as waste. The spots were then shrunk by the addition of 50 μl of 50% acetonitrile/25 mM ammonium bicarbonate, again the spots were vortexed and left to sit for 10 minutes; the liquid was discarded as waste. The spots were then reduced by the addition of 30 μl of 10 mM DTT solution for 30 minutes and incubation at 56°C, the supernatant liquid was discarded as waste. The spots were alkylated next by the addition of 30 μl of iodoacetamide for 15 minutes in the dark at room temperature. The supernatant liquid was again removed and discarded as waste. The protein spots were then shrunk again by the addition of 50 μl of 50% acetonitrile/25 mM ammonium bicarbonate. The mix was vortexed and left to stand for 15 minutes, the supernatant was discarded as waste. The protein spots were then digested with trypsin. Each spot was covered with 13 ng/μl of trypsin, and the gel pieces were incubated overnight at 37°C. The tubes were removed from incubation and the liquid surrounding the gel pieces was transferred to a corresponding fresh sterile 500 μl microfuge tube. The tryptic peptides were sequentially extracted with 20 μl of each of the following: 25 mM ammonium bicarbonate, 5% trifluoroacetic acid (TFA), and 20 μl of 100% acetonitrile. The extracted peptides were dried in the SpeedVac for approximately 2.5 hours to decrease the volume from approximately 100 μl to 10 μl. Samples were subjected to MALDI-TOF Mass spectrometry (North Eastern Ontario Regional Cancer Center, Sudbury, Ontario). Proteins were identified using the Profound [12] server (http://prowl.rockefeller.edu/prowl-cgi/profound.exe).

Results

Bioinformatic analysis of the putative secretome of M. capricolum

Using the in-house program ExProt the entire predicted proteome of M. capricolum was treated for identifying proteins with signal sequences similar to Type I (secretory) or Type II (lipoproteins) signal sequences of Gram positive bacteria. Out of the 812 proteins from the M. capricolum genome (Accession # NC_007633) 247 of the proteins were identified as having either of these two signal sequences. Members of this set were then individually processed through the SignalP server which confirmed 60 lipoproteins (signal peptidase II) and 55 nonlipoproteins (signal peptidase I) within this set (Tables 1 and 2). This “filtered” set of proteins constitutes the core secretome and makes up about 14% of the total theoretical proteome of this pathogen.

# Locus Tag Protein Name Protein ID
1 MCAP_0017 ATP-dependent metalloprotease FtsH YP_424015.1
2 MCAP_0018 hypothetical protein YP_424016.1
3 MCAP_0019 hypothetical protein YP_424017.1
4 MCAP_0095 hypothetical protein YP_424089.1
5 MCAP_0108 hypothetical protein YP_424100.1
6 MCAP_0115 hypothetical protein YP_424107.1
7 MCAP_0116 oligopeptide ABC transporter,
oligopeptide-binding protein, putative
YP_424108.1
8 MCAP_0135 hypothetical protein YP_424126.1
9 MCAP_0165 oligopeptide ABC transporter,
oligopeptide-binding protein, putative
YP_424155.1
10 MCAP_0168 hypothetical protein YP_424158.1
11 MCAP_0200 spermidine/putrescine ABC transporter, permease
protein and spermidine/putrescine-binding protein
YP_424187.1
12 MCAP_0203 50S ribosomal protein L20 YP_424190.1
13 MCAP_0204 50S ribosomal protein L35 YP_424191.1
14 MCAP_0240 hypothetical protein YP_424227.1
15 MCAP_0256 Oxidoreductase, short chain
dehydrogenase/reductase family
YP_424242.1
16 MCAP_0265 hypothetical protein YP_424251.1
17 MCAP_0270 ABC transporter, permease protein, putative YP_424256.1
18 MCAP_0271 hypothetical protein YP_424257.1
19 MCAP_0299 hypothetical protein YP_424285.1
20 MCAP_0305 hypothetical protein YP_424291.1  
21 MCAP_0328 hypothetical protein YP_424313.1
22 MCAP_0345 hypothetical protein YP_424329.1
23 MCAP_0347 hypothetical protein YP_424331.1
24 MCAP_0349 hypothetical protein YP_424333.1
25 MCAP_0351 hypothetical protein YP_424335.1
26 MCAP_0357 hypothetical protein YP_424341.1
27 MCAP_0360 hypothetical protein YP_424344.1
28 MCAP_0361 hypothetical protein YP_424345.1
29 MCAP_0362 hypothetical protein YP_424346.1
30 MCAP_0381 hypothetical protein YP_424361.1
31 MCAP_0386 50S ribosomal protein L32 YP_424366.1
32 MCAP_0398 hypothetical protein YP_424378.1
33 MCAP_0399 hypothetical protein YP_424379.1
34 MCAP_0401 hypothetical protein YP_424381.1
35 MCAP_0435 hypothetical protein YP_424409.1
36 MCAP_0444 hypothetical protein YP_424418.1
37 MCAP_0511 hypothetical protein YP_424484.1
38 MCAP_0522 hypothetical protein YP_424494.1
39 MCAP_0547 30S ribosomal protein S16 YP_424518.1
40 MCAP_0567 hypothetical protein YP_424536.1
41 MCAP_0638 hypothetical protein YP_424606.1
42 MCAP_0657 hypothetical protein YP_424622.1
43 MCAP_0664 hypothetical protein YP_424628.1
44 MCAP_0680 50S ribosomal protein L18 YP_424644.1
45 MCAP_0691 50S ribosomal protein L22 YP_424655.1
46 MCAP_0692 30S ribosomal protein S19 YP_424656.1
47 MCAP_0731 ABC transporter, substrate-binding protein YP_424691.1
48 MCAP_0735 hypothetical protein YP_424695.1
49 MCAP_0736 hypothetical protein YP_424696.1
50 MCAP_0737 hypothetical protein YP_424697.1
51 MCAP_0738 hypothetical protein YP_424698.1
52 MCAP_0763 hypothetical protein YP_424713.1
53 MCAP_0825 phosphonate ABC transporter, phosphonate-binding protein, putative YP_424772.1
54 MCAP_0842 hypothetical protein YP_424784.1
55 MCAP_0864 hypothetical protein YP_424806.1

Table 1: Secreted / exported signal peptidase I proteins, predicted through the use of ExProt (ExProt) and SignalP 3.0 server.

# Name of Proteins Locus tag Protein ID
1 lipoprotein, putative MCAP_0033 YP_424031.1
2 lipoprotein, putative MCAP_0034 YP_424032.1
3 lipoprotein, putative MCAP_0042 YP_424039.1
4 lipoprotein, putative MCAP_0059 YP_424055.1
5 lipoprotein, putative MCAP_0072 YP_424067.1
6 lipoprotein, putative MCAP_0172 YP_424162.1
7 lipoprotein, putative MCAP_0211 YP_424198.1
8 lipoprotein, putative MCAP_0212 YP_424199.1
9 lipoprotein, putative MCAP_0231 YP_424218.1
10 lipoprotein, putative MCAP_0242 YP_424229.1
11 lipoprotein, putative MCAP_0268 YP_424254.1
12 lipoprotein, putative MCAP_0269 YP_424255.1
13 lipoprotein, putative MCAP_0272 YP_424258.1
14 lipoprotein, putative MCAP_0273 YP_424259.1
15 lipoprotein, putative MCAP_0287 YP_424273.1
16 lipoprotein, putative MCAP_0312 YP_424298.1
17 lipoprotein, putative MCAP_0329 YP_424314.1
18 lipoprotein, putative MCAP_0346 YP_424330.1
19 lipoprotein, putative MCAP_0348 YP_424332.1
20 lipoprotein, putative MCAP_0350 YP_424334.1
21 lipoprotein, putative MCAP_0352 YP_424336.1
22 lipoprotein, putative MCAP_0409 YP_424384.1
23 lipoprotein, putative MCAP_0431 YP_424405.1
24 lipoprotein, putative MCAP_0432 YP_424406.1
25 lipoprotein, putative MCAP_0433 YP_424407.1
26 lipoprotein, putative MCAP_0442 YP_424416.1
27 lipoprotein, putative MCAP_0451 YP_424425.1
28 lipoprotein, putative MCAP_0470 YP_424444.1
29 lipoprotein, putative MCAP_0471 YP_424445.1
30 lipoprotein, putative MCAP_0513 YP_424485.1
31 lipoprotein, putative MCAP_0514 YP_424486.1
32 lipoprotein, putative MCAP_0524 YP_424496.1
33 lipoprotein, putative MCAP_0525 YP_424497.1
34 lipoprotein, putative MCAP_0526 YP_424498.1
35 lipoprotein, putative MCAP_0561 YP_424530.1
36 lipoprotein, putative MCAP_0583 YP_424552.1
37 lipoprotein, putative MCAP_0585 YP_424554.1
38 lipoprotein, putative MCAP_0584 YP_424553.1
39 lipoprotein (VmcD) MCAP_0593 YP_424561.1
40 lipoprotein (VmcC) MCAP_0594 YP_424562.1
41 lipoprotein (VmcB) MCAP_0595 YP_424563.1
42 lipoprotein (VmcA) MCAP_0596 YP_424564.1
43 lipoprotein, putative MCAP_0605 YP_424573.1
44 lipoprotein, putative MCAP_0607 YP_424575.1
45 lipoprotein (VmcE) MCAP_0629 YP_424597.1
46 lipoprotein (VmcF) MCAP_0630 YP_424598.1
47 lipoprotein, putative MCAP_0648 YP_424614.1
48 lipoprotein, putative MCAP_0661 YP_424625.1
49 lipoprotein, putative MCAP_0704 YP_424664.1
50 lipoprotein, putative MCAP_0720 YP_424680.1
51 lipoprotein, putative MCAP_0721 YP_424681.1
52 lipoprotein, putative MCAP_0723 YP_424683.1
53 lipoprotein, putative MCAP_0727 YP_424687.1
54 lipoprotein, putative MCAP_0758 YP_424709.1
55 lipoprotein, putative MCAP_0770 YP_424719.1
56 lipoprotein, putative MCAP_0782 YP_424731.1
57 lipoprotein, putative MCAP_0799 YP_424747.1
58 lipoprotein, putative MCAP_0801 YP_424749.1
59 lipoprotein, putative MCAP_0843 YP_424785.1
60 lipoprotein, putative MCAP_0846 YP_424788.1

Table 2: Secreted / exported Lipoproteins (signal peptidase II proteins) from Mycoplasma capricolum, predicted through the use of ExProt (ExProt).

API ZYM enzyme profiling

Culture supernatants were profiled for enzyme activities to compare with the findings of the bioinformatics and experimental protein identifications. This enzyme assay system provides qualitative evaluation of 20 enzyme activities. Culture supernatants of M. capricolum displayed similar enzyme activity profiles with 7 positive out of a total of 20 activities screened in this test (Table 3). These were the acid and alkaline phosphatases, C4 and C8 esterases/lipases, phosphohydrolase, β-galactosidase, and β-glucuronidase. There were distinct differences between the two culture supernatants however where the CFP from the acidic media showed higher activity for 4 of those enzymes: the acid and alkaline phosphatase, the C8 esterase/lipase, and the phosphohydrolase. This CFP also showed activity for 2 additional enzymes not detected in the neutral CFP: leucine arylamidase and α-chymotrypsin.

Number Enzyme Substrate Filtrate from neutral pH Filtrate from acidic pH
1 CONTROL   - -
2 Alkaline phospatase 2-naphthyl phosphate + ++
3 Esterase (C 4) 2-naphthyl butyrate + +
4 Esterase Lipase (C 8) 2-naphthyl caprylate + ++
5 Lipase (C 14) 2-naphthyl myristate -  
6 Leucine arylamidase L-leucly-2-naphthylamide - +
7 Valine arylamidase L-valyl-2-naphthylamide - -
8 Cystine arylamidase L-cystyl-2-naphthylamide - -
9 Trypsin N-benzoyl-DL-arginine-2-naphthylamide - -
10 α-chymotrypsin N-glutaryl-phenylalanine-2-naphthylamide - +
11 Acid phosphatase 2-naphthyl phosphate ++ +++
12 Naphthol-AS-BI-phosphohydrolase Naphthol-AS-BI-phosphate + ++
13 α-galactosidase 6-Br-2-naphthyl-αD-galactopyranoside - -
14 β-galactosidase 2-naphthyl-αD-galactopyranoside + +
15 β-glucoronidase Naphthol-AS-BI-βD-glucuronide + +
16 α-glucosidase 2-naphthyl-αD-glucopyranoside - -
17 β-glucosidase 6-Br-2-naphthyl-βD-glucopyranoside - -
18 N-acetyl-β-glucosamidase 1-naphthyl-N-acetyl-βD-glucosamide - -
19 α-mannosidase 6-Br-2-naphthyl-αD-mannopyranoside - -
20 α-fucosidase 2-naphthyl-αL-fucopyranoside - -

Table 3: Enzymatic profiling of the culture filtrates of M. capricolum.

Proteomic analysis of culture supernatants

It was generally observed that the growth of M. capricolum in the acidic medium was retarded compared to that at neutral pH. It was also noted that the protein content of the acidic culture filtrate was consistently less compared to that at neutral pH. Representative maps of the 2D gels are presented in Figures 1 and 2. A total of 82 gel spots can be resolved from the 2D map of the neutral CFP (Figure 1) and 111 spots were recorded for the acidic CFP (Figure 2) using silver staining. Superimposition of both maps (not shown) revealed that 18 spots were unique to the neutral CFP which are numbered 4, 15, 23, 37, 58, 59, 60, 61, 62, 63, 70, 72, 74, 77, 78, and 82. The composite image also showed 26 spots that were unique to the acidic CFP and included spot numbers 83-108. It is important to note here however that there is no information on whether these represent unique proteins or simply proteolytic fragments of others. A significant number of protein spots failed to provide usable tryptic peptide fingerprint and were thus not identified. From the neutral CFP gel, a total of 27 proteins were identified (Table 4) compared to 12 proteins for the acidic CFP gel (Table 5).

proteomics-bioinformatics-culture-filtrate-proteins

Figure 1: 2D-PAGE reference map of the culture filtrate proteins of neutral culture of M. capricolum.

proteomics-bioinformatics-culture-filtrate-proteins

Figure 2: 2D-PAGE reference map of the culture filtrate proteins of acidic culture of M. capricolum.

Spot Locus Tag Protein Name Theo. Mass (Dalton) Theo. pI Peptide Match(es)
1 MCAP_0581 inorganic pyrophosphatase 21437.85 4.82 1179.7
2 MCAP_0064 UTP-glucose-1-phosphate uridylyltransferase 33187.53 5.37 829.5, 1021.6
3 MCAP_0309 conserved hypothetical protein 35583.32 5.21 862.2, 948.8, 1215.8
4 MCAP_0193 oligoendopeptidase F 70054.66 5.28 934.7, 1153.8, 1259.8, 1508.3, 1569.0, 1685.1, 1949.3, 1993.4
5 MCAP_0213 Enolase 49490.56 5.25 817.3, 878.2
6 MCAP_0490 dihydroxyacetone kinase 2 domain protein 61049.62 5.23 877.2, 861.2, 879.2, 2344.2
7 MCAP_0390 cell division protein FtsZ 40663.96 4.55 831.6, 845.7, 2226.3
8 MCAP_0583 lipoprotein, putative 86704.75 5.48 829.6, 861.2, 877.2, 917.7, 1021.7, 1151.7, 1233.6, 1242.8, 1332.9, 1435.9, 1772.2, 2053.4, 2511.3
9 MCAP_0193 oligoendopeptidase F 70054.66 5.28 934.7, 1153.8, 1259.8, 1508.3, 1569.0, 1685.1, 1949.3, 1993.4
10 MCAP_0242 lipoprotein, putative 90183.47 8.85 809.3, 921.7, 935.7, 1006.8, 1065.8, 1181.9, 1303.9, 1526.1, 1481.0, 1714.1
11 MCAP_0610 Transketolase 72762.48 6.24 914.5, 1765.8, 2225.2
12 MCAP_0610 Transketolase 72762.48 6.24 914.5, 1765.8, 2225.2
13 MCAP_0033 lipoprotein, putative (LppA) 60391.19 8.64 855.1, 878.1, 1569.0, 1684.1, 1993.3, 2186.2, 2400.2
14 MCAP_0420 dipeptidase, putative 50815.03 5.10 915.1, 963.6, 1074.6, 1375.8, 1507.0, 2064.0, 2311.2
15 MCAP_0127 cytosol aminopeptidase 49799.58 5.60 895.1, 933.6, 1088.1, 1274.7, 1700.0, 1701.1, 2221.2, 2190.1, 2705.3
16 MCAP_0042 lipoprotein, putative 61703.30 5.20 829.5, 861.2, 867.2, 1052.7, 1060.6, 1077.6, 1103.6, 1175.7, 1180.7,
1274.8, 1333.8, 1700.1, 1746.1, 2226.3,
17 MCAP_0194 conserved hypothetical protein 26372.97 4.71 849.5, 861.2, 993.6, 977.6, 1200.7, 2204.2
18 MCAP_0583 lipoprotein, putative 86704.75 5.48 829.5, 861.2, 877.1, 917.6, 1021.6, 1036.6, 1191.6, 1213.7, 1243.8, 1332.8, 1399.8, 1434.9, 1435.9, 1553.9, 1610.9, 1698.1, 1743.0, 1772.2, 2069.2, 2053.3, 2070.2, 2130.1, 2193.1, 2400.2
19 MCAP_0447 glycine cleavage system H protein, putative 13423.00 5.43 973.7, 1104.7, 1234.8, 1401.9, 1641.1, 1718.0, 1709.0, 1989.2, 2551.4, 2612.5
20 MCAP_0177 conserved hypothetical protein 14930.53 5.79 867.5, 1365.8, 1413.8, 1437.9, 1640.0, 1669.0, 1818.2
21 MCAP_0859 pyrazinamidase/nicotinamidase 18971.39 5.39 914.6, 895.6, 918.6, 1104.6, 1456.9, 1816.2, 2008.3, 2502.4
22 MCAP_0285 hypothetical protein 19142.74 4.60 956.3, 1109.7, 1186.7, 1729.1
23 MCAP_0308 conserved hypothetical protein 21383.15 4.31 867.5, 935.5, 1141.6, 2834.2
24 MCAP_0431 lipoprotein, putative 23800.42 4.70 828.5, 829.4, 891.4, 900.5, 931.5, 933.4, 973.5, 1588.8, 1874.8, 2744.3
25 MCAP_0433 lipoprotein, putative 24158.38 4.92 862.1, 878.1, 978.6, 1151.7, 1155.7, 1420.9, 2038.2, 2932.7
26 MCAP_0804 zinc metalloprotease, putative 27844.82 9.46  852.6, 914.6, 1041.6, 1126.7, 1112.7, 1288.8, 1610.9, 1640.1, 1850.1
27 MCAP_0763 membrane protein, putative 25949.18 9.43 831.5, 867.2, 966.6, 979.6, 1085.6, 1154.7, 1259.8, 1236.7, 1393.8, 2225.3, 2874.4, 2932.6
28 MCAP_0237 30S ribosomal protein S4 23870.91 10.08 927.6, 1002.6, 1163.7, 1223.7, 1254.7, 1308.8, 1428.9, 1841.1, 1919.0, 2189.2, 2195.2

Table 4: List of identified proteins from the culture filtrate of neutral culture of M. capricolum.

Spot Locus Tag Protein Name Theo. Mass (Dalton) Theo. pI Peptide Match(es)
1 MCAP_0587 ABC transporter, ATP binding protein, putative 71588.27 6.34 808.7, 828.8, 851.8, 852.8, 877.4, 894.4, 907.9, 1088.4, 1266.1, 1597.4, 1676.3.
2 MCAP_0033 Lipoprotein, putative (LppA) 60391.19 8.64 847.5, 878.4, 915.3, 932.3, 1219.4, 1565.4.
3 MCAP_0195 Cytosol aminopeptidase 49831.5 5.90 863.5, 1300.7, 1332.8, 1332.1, 1332.5, 1421.2, 1421.4, 1597.8.
4 MCAP_0359 FοF1 ATP synthase subunit beta 51302.8 5.10 861.4, 954.6, 1109.6, 1509.8, 1569.7.
5 MCAP_0722 Peptide methionine sulfoxide reductase (mrsA/mrsB) 35732.66 5.46 898.8, 1279.1, 1288.1, 1793.3, 1905.7, 2164.8.
6 MCAP_0055 Hemolysin A 31160.50 9.14 831.7, 1003.8, 1586.1.
7 MCAP_0816 Hypothetical protein 25074.12 5.42 833.3, 877.3, 878.3, 909.3.
8 MCAP_0599 Nucleoside kinase 24310.95 5.80 992.4, 1126.4, 1133.7, 1834.6, 1922.7.
9 MCAP_0251 Transcription  elongation factor GreA 17493.1 5.80 802.4, 858.4, 1069.6
10 MCAP_0175 Hypothetical protein 16409.8 4.80 1303.8, 1534.8,1878.9, 2386.2.
11 MCAP_0300 Hypothetical protein 57728.04 5.18 863.4, 878.4, 1274.6.
12 MCAP_0420 Dipeptidase, putative 50845.03 5.10 939.5, 996.9, 1192.9, 1235.4, 1359.1,

Table 5: List of identified proteins from the culture filtrate of acidic culture of M. capricolum.

Discussion

Treatment of the theoretical proteome of M. capricolum with our in-house program ExProt resulted in a predicted secretome size of 247 proteins out of a total proteome size of 812 proteins. This fraction of the proteome (30.4%) is comparable to predicted secretomes of other mycoplasmas including M. pneumonia (37%) and M. genitalium (24%) predicted with the same program [7]. A value of 32% for the M. pneumonia secretome was reported using the LocateProtein program [7]. These secretome sizes fall in the high end of the spectrum for secretome sizes and inspection of the predicted secretome of M. capricolum reveals that this high size possibly due to the large number of predicted lipoproteins as part of the secretome. Over 7% of the proteome of M. capricolum could potentially represent lipoproteins (Table 2). Treatment of the proteome using the SignalP program reduced the secretome size from 247 proteins to 115, including the 60 predicted lipoproteins (Table 2). This reduces the secretome size from 30% to 14%. SignalP predicted 55 proteins with Type I signal sequence with a composition made up mostly of hypothetical proteins, transport proteins, and proteins involved in protein synthesis (Figure 3).

proteomics-bioinformatics-functional-predicted-secretome

Figure 3: Functional grouping of the predicted secretome of M. capricolum.

Enzymatic profiling of the culture supernatants of M. capricolum identified 7 enzyme activities in the neutral and acidic culture supernatants of M. capricolum. These were the acid and alkaline phosphatases, C4 and C8 esterases/lipases, phosphohydrolase, β-galactosidase, and β-glucuronidase. There were distinct differences between the two culture supernatants however where the CFP from the acidic media showed higher activity for 4 of those enzymes: the acid and alkaline phosphatase, the C8 esterase/lipase, and the phosphohydrolase. This CFP also showed activity for 2 additional enzymes not detected in the neutral CFP: leucine arylamidase and α-chymotrypsin. What was more curious however is the observation that the predicted secretome did not contain any proteins that could account for the observed enzymatic activities. This result was unusual and it’s not clear why at this time. The ExProt and SignalP programs have been tested previously on many proteomes and their comparative prediction power was established many years ago [7]. If it is not the quality of the predictive programs then what the possible reasons for this observation. Cell lysis contribution as a possibility was looked at by measuring the levels of the cytoplasmic enzyme lactate dehydrogenase. Typical values for this activity in the CFP’s used in this study were typically 10% that of the cytoplasmic extracts (data not shown). This activity is regularly used as part of the quality control of the CFP’s used in our study. Other possible reasons may include for instance the dependence of M. capricolum on other secretory pathways to excrete proteins and that the general secretory pathway may only play a minor role in protein secretion in this bacterium. We should also not dismiss the fact that a large number of the predicted proteins in the secretome of M. capricolum have unknown functions (Tables 1 and 2). It is therefore possible that the observed enzymatic activities in the CFP’s are in fact due to correctly predicted components of the secretome but have been annotated as having unknown functions due to lack of homologous proteins for sequence comparison.

The genomes of several mycoplasma species include distinctive sets of genes that encode different surface lipoproteins [13]. For the most part, it seems that these lipoproteins remain functionally unknown. However, some research suggests that surface lipoproteins confer both protective and opportunistic capabilities to M. capricolum based on analogous proteins. Lipoproteins of M. hyorhinis or M. pulmonis protect these pathogens from immunological targeting by host antibodies [14] and complement [15]. Additional functions for these surface proteins include the phase variation that is produced by mutations in certain gene clusters such as the variable M. capricolum subsp. capricolum (Vmc). The predicted secretome of M. capricolum contains the six Vmc (A-F) lipoproteins (Table 2). These genes and their products have been well characterized [13]. From the CFP of the M. capricolum grown at neutral pH a total of 28 proteins were identified by trypsin digest and MALDI-TOF mass spectrometry (Table 4). A major component of this fraction contained putative lipoproteins (8 out of 28, or 29%). The second major component of the CFP was made up of hypothetical proteins (5 out of 28, or 18%). The abundance of these two groups of proteins identified in this CFP matches that obtained through the bioinformatics analysis (Tables 1 and 2, Figure 3) where the lipoproteins and the hypothetical proteins represented the largest two fractions of the predicted secretome. A recent report by Couto et al. [16] outlined the identification of 19 proteins from the CFP fraction of M. synoviae cultured in modified Frey’s medium. From the 19 identified proteins 3 were listed as hypothetical proteins. This is similar to our results were the hypothetical proteins made up 18% of the extracellular fraction. The authors did not report the presence of any lipoproteins in their findings. There have been several other proteomic studies of various mycoplasmas in the past few years but none of them focussed on the exported/secreted proteins [17-21]. Other notable findings in our study include the identification of several peptidases. A total of 4 different proteases were identified in 5 spots from the 2D gels (Table 4) to include oligoendopeptidase F (spots 4 and 9), dipeptidase, cytosol aminopeptidase, and zinc metalloprotease. Gelatinases are metalloproteases and in our study gelatin zymography confirmed the presence of gelatinase activity in the CFP of M. capricolum (results not shown). The zinc metalloprotease identified in the CFP from the neutral culture medium (MCAP_0804) may be responsible for this activity. Aminopeptidases are exopeptidases that release N-terminal amino acid residues from their substrates; see review by Gonzales and Robert-Baudouy [22]. Aminopeptidase activity is well established in mycoplasma and is used in classification and identification of these microorganisms [23-25], including M. capricolum [26]. Although none of those studies looked at the secretome, aminopeptidases can be secreted and not only found in the cytosol or associated with the membrane or envelope in bacteria [22].

The 2D gel profile and the number of identified proteins of the CFP from the acidic media of M. capricolum were generally less complex than that from the neutral media. The bacterium did show reduced growth potential in acidic media and the reduced complexity of the CFP profile may be a reflection of this observation. A total of 12 proteins identified in this acidic CFP and its composition showed marked differences in comparison to that from neutral CFP. Of all the identified neutral and acidic proteins there were 3 that were seen in the secretome of M. capricolum at both a neutral and acidic pH. These included a putative lipoprotein (LppA), a putative dipeptidase, and a cytosol aminopeptidase. Only one lipoprotein in comparison was identified and the number of hypothetical proteins was 2. The acidic CFP also contained a putative hemolysin, a protein not identified in the neutral CFP. A previous study reported on the hemolytic activity of a number of mycoplasmas but not in M. capricolum [27]. One other protein of interest identified in the CFP from acidic growth media was the peptide methionine sulfoxide reductase (MCAP_0722; Table 5). This type of enzyme is typically involved in protecting bacteria from oxidative stress but a deletion mutant from M. genitalium was shown to exhibit reduced cytadherence and virulence [28].

Enzymatic profiling of both CFP’s was evaluated to compare with the identification of the proteins in these preparations. The CFP from the neutral culture of M. capricolum contained a number of proteins that could explain some of the enzymatic activities observed in this protein fraction and includes the phosphatase, aryl amidase, and peptidase activities. No proteins were identified to explain the other enzymatic activities identified by the API ZYME system. Similarly, no proteins were identified in the acidic CFP that would explain those enzyme activities identified by the API ZYME system. The 2D gels however show a number of proteins for which the trypsin digestion and mass spectrometry failed to identify. What could possibly aid in the functional classification of the large number of functionally unknown proteins are the recent developments in the field of genome transplantation [29]. Gene knockout experiments are limited by the fact that gene function can be redundant and phenotypic changes associated with certain gene knockouts would thus not be observed to hint to a possible gene function. An additional limitation to these experiments is functional compensation where loss of a specific gene function is compensated for by up-regulation of other gene products. Genome transplantation on the other hand allows for deletion of large segments or gene clusters without causing fatal consequences to the recipient cell. The recent engineering of Mycoplasma mycoides JCVI [30] attests to the promise that this technique can be attainable and can provide a wealth of information on genome evolution and function.

Competing Interests

The authors declared that there are no competing interests.

Acknowledgements

We would like to thank Dr. Pascal Sirand-Pugnet (Institut national de la recherche agronomique, INRA, France) for providing us with the culture of mycoplasma used in this study. This work was supported in part by a research grant from the Laurentian University Research Fund (LURF).

References

  1. Rottem S (2003) Interaction of mycoplasmas with host cells. Physiol Rev 83: 417-432.
  2. Razin S, Yogev D, Naot Y (1998) Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev 62: 1094-1156.
  3. Cordwell SJ (2006) Technologies for bacterial surface proteomics. Curr Opin Microbiol 9: 320-329.
  4. Snel B, Bork P, Huynen MA (1999) Genome phylogeny based on gene content. Nat Genet 21: 108-110.
  5. Baseman JB, Tully JG (1997) Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety. Emerg Infect Dis 3: 21-32.
  6. Darzi MM, Sood N, Gupta PP, Banga HS (1998) The pathogenicity and pathogenesis of Mycoplasma capricolum subsp. capripneumoniae (F38) in the caprine mammary gland. Vet Res Commun 22: 155-165.
  7. Saleh MT, Fillon M, Brennan PJ, Belisle JT (2001) Identification of putative exported/secreted proteins in prokaryotic proteomes. Gene 269: 195-204.
  8. Nielsen H, Engelbrecht J, Brunak S, von Heijne G (1997) Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Prot Engineer 10: 1-6.
  9. Voros A, Dunnett A, Leduc LG, Saleh MT (2009) Depleting proteins from the growth medium of Mycoplasma capricolum unmasks bacterium-derived enzymatic activities. Vet Microbiol 138: 384-389.
  10. Blum H, Beier H, Gross HJ (1987) Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 8: 93-99.
  11. Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850-858.
  12. Zhang W, Chait BT (2000) ProFound: an expert system for protein identification using mass spectrometric peptide mapping information. Anal Chem 72: 2482-2489.
  13. Wise KS, Foecking MF, Röske K, Lee YJ, Lee YM, et al. (2006) Distinctive repertoire of contingency genes conferring mutation-based phase variation and combinatorial expression of surface lipoproteins in Mycoplasma capricolum subsp. capricolum of the mycoplasma mycoides phylogenetic cluster. J Bacteriol 188: 4926-4941.
  14. Citti C, Kim MF, Wise KS (1997) Elongated versions of Vlp surface lipoproteins protect Mycoplasma hyorhinis escape variants from growth-inhibiting host antibodies. Infect Immun 65: 1773-1785.
  15. Simmons WL, Denison AM, Dybvig K (2004) Resistance of Mycoplasma pulmonis to complement lysis is dependent on the number of Vsa tandem repeats: shield hypothesis. Infect Immun 72: 6846-6851.
  16. Rebollo Couto MS, Klein CS, Voss-Rech D, Terenzi H (2012) Extracellular Proteins of Mycoplasma synoviae. ISRN Vet Sci 2012: 802308.
  17. Jaffe JD, Stange-Thomann N, Smith C, DeCaprio D, Fisher S, et al. (2004) The complete genome and proteome of Mycoplasma mobile. Genome Res 14: 1447-1461.
  18. Menegatti AC, Tavares CP, Vernal J, Klein CS, Huergo L, et al. (2010) First partial proteome of the poultry pathogen Mycoplasma synoviae. Vet Microbiol 145: 134-141.
  19. 19. Kühner S, van Noort V, Betts MJ, Leo-Macias A, Batisse C, et al. (2009) Proteome organization in a genome-reduced bacterium. Science 326: 1235-1240.
  20. Kühner S, van Noort V, Betts MJ, Leo-Macias A, Batisse C, et al. (2009) Proteome organization in a genome-reduced bacterium. Science 326: 1235-1240.
  21. Pinto PM, Klein CS, Zaha A, Ferreira HB (2009) Comparative proteomic analysis of pathogenic and non-pathogenic strains from the swine pathogen Mycoplasma hyopneumoniae. Proteome Sci 7: 45.
  22. Wasinger VC, Pollack JD, Humphery-Smith I (2000) The proteome of Mycoplasma genitalium. Chaps-soluble component. Eur J Biochem 267: 1571-1582.
  23. Gonzales T, Robert-Baudouy J (1996) Bacterial aminopeptidases: properties and functions. FEMS Microbiol Rev 18: 319-344.
  24. Wan X, Branton SL, Hughlett MB, Hanson LA, Pharr GT (2004) Experssion and Subcellular Location of Leucine Aminopeptidase of Mycoplasma gallinarum. Int J Poult Sci 3: 70-74.
  25. Watanabe T, Shibata K, Totsuka M (1984) Aminopeptidase and caseinolytic activities of Mycoplasma salivarium. Med Microbiol Immunol 172: 257-264.
  26. Neill SD, Ball HJ (1980) Aminopeptidase activity of Acholeplasma laidlawii, Mycoplasma bovirhinis, Mycoplasma dispar and Mycoplasma bovis. J Gen Microbiol 119: 103-107.
  27. Ball HJ, Neill SD, Reid RL (1985) Aminopeptidase activity in arginine-utilizing Mycoplasma spp. J Clin Microbiol 21: 859-860.
  28. Cole BC, Ward JR, Martin CH (1968) Hemolysin and peroxide activity of Mycoplasma species. J Bacteriol 95: 2022-2030.
  29. Dhandayuthapani S, Blaylock MW, Bebear CM, Rasmussen WG, Baseman JB (2001) Peptide methionine sulfoxide reductase (MsrA) is a virulence determinant in Mycoplasma genitalium. J Bacteriol 183: 5645-5650.
  30. Lartigue C, Glass JI, Alperovich N, Pieper R, Parmar PP, et al. (2007) Genome transplantation in bacteria: changing one species to another. Science 317: 632-638.
Citation: Voros A, DeLongchamp J, Saleh M (2015) The Secretome of Mycoplasma capricolum subsp. capricolum in Neutral and Acidic Media. J Proteomics Bioinform 8: 155-163.

Copyright: © 2015 Voros A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top